Enroll your hospital
If you would like to enroll your hospital in our Hospital Access Patient Assistance Program, please download the application or just give us a call at 1-800-652-6227 to request an application. This program operates using a product replacement model. Hospitals are eligible to participate if they participate in the 340B drug pricing program and are classified as a disproportionate share hospital. This program is for outpatients only, and product must be dispensed from an outpatient pharmacy.
Hospitals that participate are required to sign a contract and agree to on-site assessments.
We offer the following prescription products for hospitals:
- DITROPAN® XL
(oxybutynin chloride)
Extended Release Tablets - DOXIL® †
(doxorubicin HCL liposome injection) for intravenous infusion - EDURANT™
(rilivrine) Tablets
- INTELENCE™
(etravirine) Tablets - INVEGA® †
(paliperidone) Extended-Release Tablets - LEVAQUIN®
(levofloxacin) Tablets/Oral Solution - PREZISTA®
(darunavir) Tablets
- PROCRIT® †
(Epoetin alfa) FOR INJECTION - RISPERDAL® †
(risperidone) M-TAB® orally disintegrating tablets - RISPERDAL® †
(risperidone) tablets / oral solution - TOPAMAX®
(topiramate) Sprinkle Capsules
- TOPAMAX®
(topiramate) Tablets - ULTRACET®
(tramadol hydrochloride / acetaminophen tablets) - XARELTO®
(rivaroxaban)
† Please see full U.S. prescribing information, including Black Box warning for:
DOXIL®,
INVEGA®,
PROCRIT®,
RISPERDAL®